MedTrace Logo

Calprotectin Levels in Necrotizing Enterocolitis

NCT06693154 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2024-11-18

No results posted yet for this study

Summary

Necrotizing enterocolitis (NEC) is a serious condition that can affect premature babies, leading to complications like intestinal damage and infection. In our study, we measured specific markers (called calprotectin) in blood and stool to understand how severe NEC is and predict outcomes. We found that these markers were higher in babies with more severe NEC (stage 3), especially in those who needed surgery or sadly did not survive. This information can help doctors detect NEC earlier, understand its severity, and make better decisions for treating affected babies.

Conditions

  • Necrotising Enterocolitis Neonatal

Sponsors & Collaborators

  • Ankara Yildirim Beyazıt University

    lead OTHER

Principal Investigators

  • Abdullah Kurt · Ankara Yildirim Beyazıt University

Eligibility

Min Age
3 Days
Max Age
30 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2024-01-01
Completion
2024-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06693154 on ClinicalTrials.gov